Contrasting Vivani Medical (NASDAQ:VANI) & Zoetis (NYSE:ZTS)

Vivani Medical (NASDAQ:VANI) and Zoetis (NYSE:ZTS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Risk & Volatility

Vivani Medical has a beta of 3.07, indicating that its stock price is 207% more volatile than the S&P 500. Comparatively, Zoetis has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and target prices for Vivani Medical and Zoetis, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1	1	1	0	2.00
Zoetis	1	7	6	0	2.36

Vivani Medical presently has a consensus target price of $4.00, suggesting a potential upside of 212.50%. Zoetis has a consensus target price of $160.18, suggesting a potential upside of 28.56%. Given Vivani Medical’s higher probable upside, equities research analysts clearly believe Vivani Medical is more favorable than Zoetis.

Insider & Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 92.8% of Zoetis shares are owned by institutional investors. 46.4% of Vivani Medical shares are owned by company insiders. Comparatively, 0.2% of Zoetis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Vivani Medical and Zoetis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-293.64%	-79.49%
Zoetis	28.21%	57.19%	19.53%

Earnings & Valuation

This table compares Vivani Medical and Zoetis”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$23.49 million	($0.45)	-2.84
Zoetis	$9.26 billion	5.93	$2.49 billion	$5.94	20.98

Zoetis has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Zoetis, indicating that it is currently the more affordable of the two stocks.

Summary

Zoetis beats Vivani Medical on 10 of the 13 factors compared between the two stocks.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.